Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

被引：0
|
作者：
Chae, Y.
Kim, J.
Sohn, S.
Kang, B.
Ryoo, H.
Bae, S.
Choi, G.
Baek, J.
Kim, Y.
Cho, Y.
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Kyungpook Natl Univ Sch Med, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Taegu, South Korea
[3] Daegu Catholic Univ Hosp, Taegu, South Korea
[4] Daegu Catholic Univ Coll Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Dongkuk Univ Hosp, Kyungju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MGMT-535G> T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kang, B. W.
    Kim, J. G.
    Chae, Y. S.
    Lee, S. J.
    Do, Y. R.
    Lee, W. S.
    ANNALS OF ONCOLOGY, 2010, 21 : 209 - 210
  • [2] MGMT-535G>T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kim, J. G. K.
    Choi, G. S. C.
    Chung, H. Y. C.
    Jun, S. H. J.
    Lim, K. H. L.
    Kang, B. W. K.
    Jeon, S. W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : I35 - I35
  • [3] MGMT-535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Park, Jee Hyun
    Kim, Nung Soo
    Park, Jae Yong
    Chae, Yee Soo
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Moon, Joon Ho
    Kang, Byung Woog
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Choi, Gyu Seog
    Jun, Soo-Han
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1135 - 1142
  • [4] MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
    Jee Hyun Park
    Nung Soo Kim
    Jae Yong Park
    Yee Soo Chae
    Jong Gwang Kim
    Sang Kyun Sohn
    Joon Ho Moon
    Byung Woog Kang
    Hun Mo Ryoo
    Sung Hwa Bae
    Gyu Seog Choi
    Soo-Han Jun
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1135 - 1142
  • [5] Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.
    Chun, Sang Hoon
    Kim, Jung Hoon
    Kwag, Seung-Jin
    Kang, Myoung Hee
    Park, Ji-Ho
    Lee, Gyeong-Won
    Kang, Jung Hun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 157 - 157
  • [6] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [7] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
  • [8] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    L Paré-Brunet
    A Sebio
    J Salazar
    A Berenguer-Llergo
    E Río
    A Barnadas
    M Baiget
    D Páez
    The Pharmacogenomics Journal, 2015, 15 : 397 - 404
  • [9] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Pare-Brunet, L.
    Sebio, A.
    Salazar, J.
    Berenguer-Llergo, A.
    Rio, E.
    Barnadas, A.
    Baiget, M.
    Paez, D.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (05): : 397 - 404
  • [10] Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy
    Shibasaki, Yuta
    Yokobori, Takehiko
    Sohda, Makoto
    Shioi, Ikuma
    Ozawa, Naoya
    Komine, Chika
    Suga, Kunihiko
    Nakazawa, Nobuhiro
    Osone, Katsuya
    Shiraishi, Takuya
    Okada, Takuhisa
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Kaira, Kyoichi
    Shirabe, Ken
    Saeki, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
12345